首页|单核细胞趋化蛋白1、骨膜蛋白与PCI术后急性心肌梗死患者预后的关系

单核细胞趋化蛋白1、骨膜蛋白与PCI术后急性心肌梗死患者预后的关系

扫码查看
目的 评估单核细胞趋化蛋白1(MCP-1)和骨膜蛋白水平与经皮冠状动脉介入治疗(PCI)术后急性心肌梗死(AMI)患者预后的关系。方法 本研究纳入2021年3月至2024年1月榆林市星元医院106例接受PCI的AMI患者,基于术后3个月内的主要不良心血管事件(MACE)发生情况,将患者分为预后不良组和预后良好组。通过酶联免疫吸附试验(ELISA)测定患者PCI术后MCP-1及骨膜蛋白水平,比较不同预后组患者MCP-1及骨膜蛋白水平,采用Spearman秩相关分析及logistic回归模型分析MCP-1、骨膜蛋白水平与PCI术后AMI患者预后的相关性,绘制受试者操作特征曲线(ROC)分析MCP-1、骨膜蛋白评估PCI术后AMI患者预后的价值。采用独立样本t检验、x2检验进行统计学分析。结果 预后良好组75例,其中男44例,女31例,年龄(65。43±5。76)岁,体重指数(23。07±0。97)kg/m2。预后不良组31例,其中男19例,女12例,年龄(65。02±5。41)岁,体重指数(22。86±0。86)kg/m2。预后不良组的MCP-1和骨膜蛋白水平均高于预后良好组[(35。57±3。65)ng/L 比(29。66±3。52)ng/L,(155。12±12。19)µg/L比(142。03±10。43)μg/L],差异均有统计学意义(均P<0。05)。相关性分析显示,MCP-1和骨膜蛋白与预后不良均呈正相关(r=0。594、0。444,均P<0。05)。logistic回归分析表明,MCP-1及骨膜蛋白水平均为预后不良的危险因素(OR=1。615、1。119,均P<0。05)。ROC分析显示,单独使用MCP-1和骨膜蛋白的曲线下面积(AUC)分别为0。877和0。782,两者联合使用时,AUC提升至0。929,灵敏度和特异度分别为87。1%和86。7%,约登指数为0。738。结论 MCP-1和骨膜蛋白水平与PCI术后AMI患者预后密切相关,可以作为判断预后不良的生物标志物。这些发现支持在临床实践中使用MCP-1和骨膜蛋白作为评估AMI患者风险和治疗反应的潜在工具。
Relationships between monocyte chemotactic protein 1 and periosteal protein levels and prognosis in patients with acute myocardial infarction after PCI
Objective To evaluate the relationships between monocyte chemotactic protein-1(MCP-1)and periosteal protein levels and prognosis in patients with acute myocardial infarction(AMI)after percutaneous coronary intervention(PCI).Methods In this study,106 patients with AMI who underwent PCI in Xingyuan Hospital of Yulin from March 2021 to January 2024 were included.Based on the occurrence of major adverse cardiovascular events(MACE)within 3 months after surgery,the patients were divided into a poor prognosis group and a good prognosis group.The levels of MCP-1 and periosteal protein were measured by enzyme-linked immunosorbent assay(ELISA)after PCI,and the levels of MCP-1 and periosteal protein in patients with different prognosis were compared.Spearman rank correlation analysis and logistic regression model were used to analyze the correlations between MCP-1 and periosteal protein levels and prognosis in AMI patients after PCI.The receiver operating characteristic curve(ROC)was drawn to analyze MCP-1 and periosteal protein in predicting the prognosis in AMI patients after PCI.Independent sample t test and x2 test were used for statistical analysis.Results In the good prognosis group,there were 44 males and 31 females,aged(65.43±5.76)years,with a body mass index of(23.07±0.97)kg/m2.In the poor prognosis group,there were 19 males and 12 females,aged(65.02±5.41)years,with a body mass index of(22.86±0.86)kg/m2.The levels of MCP-1 and periosteal protein in the poor prognosis group were higher than those in the good prognosis group[(35.57±3.65)ng/L vs.(29.66±3.52)ng/L,(155.12±12.19)μg/L vs.(142.03±10.43)μg/L],with statistically significant differences(both P<0.05).Correlation analysis showed that both MCP-1 and periosteal protein were positively correlated with poor prognosis(r=0.594 and 0.444,both P<0.05).Logistic regression analysis showed that both MCP-1 and periosteal protein were risk factors for poor prognosis(OR=1.615 and 1.119,both P<0.05).ROC analysis showed that the areas under the curves(AUCs)of MCP-1 and periosteal protein alone were 0.877 and 0.782,respectively.When MCP-1 and periosteal protein were used in combination,the AUC increased to 0.929,the sensitivity and specificity were 87.1%and 86.7%,respectively,and the Yoden index was 0.738.Conclusions MCP-1 and periosteal protein levels are closely related to the prognosis of AMI patients after PCI,and can be used as biomarkers for predicting poor prognosis.These findings support the use of MCP-1 and periosteal protein as potential tools for assessing risk and treatment response in AMI patients in clinical practice.

Acute myocardial infarctionPercutaneous coronary interventionMonocyte chemotactic protein 1Periosteal proteinPrognosis

刘建建、杜鹏荣、王蕊

展开 >

榆林市星元医院心血管内科,榆林 719000

急性心肌梗死 经皮冠状动脉介入治疗 单核细胞趋化蛋白1 骨膜蛋白 预后

2024

国际医药卫生导报
中华医学会,国际医药卫生导报社

国际医药卫生导报

影响因子:0.781
ISSN:1007-1245
年,卷(期):2024.30(24)